kresmion.
Pull a receipt
PREVIEW · SAMPLE DATA
This is the NMRA dossier with made-up numbers. Sign up free to see live prices, insider trades, 13F flows and fundamentals for NMRA.

NMRA

Neumora Therapeutics, Inc.
Healthcare · Biotechnology
$163.72 sample
-1.54 (-0.93%) 1D
☆ Watch
Market cap
$203.6B
Price as of
2026-10-29
Latest filing
8-K · 2026-10-15
Alerts
8
Price$163.72 +5.10% 3M daily closessample
166.11150.09
2026-08-032026-08-252026-09-162026-10-072026-10-29
purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first
  • Oct 27INSInsider sell: EVP, Operations
  • Oct 21INSInsider sell: General Counsel
  • Oct 15SECDEF 14A filed
  • Oct 06INSInsider buy: 10% owner
  • Sep 28INSInsider sell: Chief Financial Officer
  • Sep 22INSInsider buy: Chief Financial Officer
  • Sep 16INSInsider buy: 10% owner
  • Sep 08INSInsider sell: Chief Financial Officer
Sign up to see the real NMRA record →

Company facts

SEC EDGAR registration
Name
Neumora Therapeutics, Inc.
Sector
Healthcare
Industry
Biotechnology
Smart-money score
+4sample, -100 to +100
Reporting currency
USD

Who is positioning in NMRA

sample
Insiders
23 insider transactions over 90 days, net selling, $296.7M
Congress
1 members traded over 90 days
Institutions · 13F
41 funds hold $5.1B
Activists · 13D/G
No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end
Revenue$13.2B +14.8% y/y
Q4 2024Q3 2026
Inventory$8.1B +13.3% y/y
Q4 2024Q3 2026
Accounts receivable$6.3B +14.4% y/y
Q4 2024Q3 2026
Total debt$16.3B +11.6% y/y
Q4 2024Q3 2026

Peers

sample
Sample peer A
$30.1B +3.0% 3M
Sample peer B
$163.3B -10.1% 3M
Sample peer C
$192.3B +1.4% 3M
Sample peer D
$169.6B +14.8% 3M
Sample peer E
$134.7B +6.7% 3M
Preview. Company name, sector and industry are from SEC EDGAR; every price, flow, filing count and fundamental on this page is sample data generated for the preview and is not NMRA's real figure. Nothing here is investment advice.